Package leaflet: information for the user. Tevanate Once Weekly 70 mg Tablets Alendronic acid

Similar documents
Package leaflet: Information for the user. Alendroarrow Veckotablett 70mg tablets. alendronic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 5 mg film-coated tablets risedronate sodium

Package leaflet: Information for the user. Alendronat 1A Farma Veckotablett 70 mg Film-coated tablets Alendronic acid

Package leaflet: Information for the patient. Alendronic Acid 70 mg Tablets. sodium alendronate

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Alendronat ratiopharm Veckotablett 70 mg tablets. Alendronic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 35 mg film-coated tablets risedronate sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 30 mg film-coated tablets risedronate sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Alendroninezuur Mylan 70 mg, tabletten. (sodium alendronate trihydrate)

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Alendronic Acid 10 mg Tablets

Package leaflet: Information for the patient. Optinate 5 mg film-coated tablets risedronate sodium

Package leaflet: Information for the user. Anastrozole Teva 1 mg Film-coated Tablets Anastrozole

PACKAGE LEAFLET: INFORMATION FOR THE USER. Famciclovir Teva 250 mg Film-coated Tablets. Famciclovir 125, 250 & 500 mg Film-coated Tablets.

Package leaflet: Information for the patient. Optinate 30 mg film-coated tablets risedronate sodium

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the user. Medarin Veckotablett 70mg Tablets (alendronic acid)

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package leaflet: Information for the user. Risedronate Bluefish 35 mg film-coated tablets Risedronate sodium

Package leaflet: Information for the patient. FOSAMAX Once Weekly 70 mg Tablets Alendronic acid

Package leaflet: Information for the patient. FOSAMAX Once Weekly 70 mg Tablets Alendronic acid

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Sibelium 5 mg Tablets flunarizine

2 What you need to know before you take Osbonelle 150 mg Do not take Osbonelle 150 mg:

Medication Guide ACTONEL (AK-toh-nel) (risedronate sodium) Tablets

1. What Betahistine dihydrochloride tablets is and what it is used for

2. What you need to know before you take DDAVP/Desmopressin Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. <Amlodipine 5 mg and 10 mgtablets> Amlodipine maleate

MEDICATION GUIDE. Boniva (bon-ee-va) (ibandronate sodium) Tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

Package Leaflet: Information for the Patient. FOSRENOL 750 mg oral powder. FOSRENOL 1000 mg oral powder. lanthanum

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

Pravat 40 mg tablets. Pravastatin sodium

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

Package leaflet: Information for the patient. Optinate Septimum 35 mg film-coated tablets risedronate sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

Package leaflet: Information for the patient

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

Package Leaflet: Information for the user. FOSAVANCE 70 mg/2,800 IU tablets FOSAVANCE 70 mg/5,600 IU tablets Alendronic acid /colecalciferol

Bonefos 400 mg capsules sodium clodronate

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the patient. Metformin Teva 1000 mg Film-coated Tablets Metformin hydrochloride

1. What Miacalcic is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

1. What Octostim Nasal Spray is and what it is used for

Package leaflet: Information for the user

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Salofalk 3g gastro-resistant prolonged-release granules. Mesalazine

Package Leaflet: Information for the Patient. FOSRENOL 750 mg chewable tablets. FOSRENOL 1000 mg chewable tablets. lanthanum

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Package leaflet: Information for the user

Lovastatin tablets 20 and 40 mg PACKAGE LEAFLET

Aciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Package leaflet: Information for the patient. Valotix 500 mg Film-Coated Tablets Valaciclovir

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets

Asacolon 400 mg and 800 mg Gastro-resistant Tablets

Atrosan Devil s Claw film-coated tablets

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

Package leaflet: Information for the user Arlevert 20 mg/40 mg tablets cinnarizine/dimenhydrinate

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tantum Verde orange-honey taste 3 mg lozenges Benzydamine Hydrochloride

Package leaflet: Information for the user. Sebivo 600 mg film-coated tablets Telbivudine

Package leaflet: Information for the user Salofalk 500mg gastro-resistant tablets Mesalazine

2 What you need to know before you take Zantac

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen exenatide

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Package Leaflet: Information for the patient. FERROUS SULFATE TABLETS 200 mg Ferrous Sulfate

Package Leaflet: Information for the User. Zomig Rapimelt 2.5 mg and 5 mg orodispersible tablets zolmitriptan

Package Leaflet: Information for the User

Package leaflet: information for the user. Valaciclovir Bluefish 500 mg Film-Coated Tablets Valaciclovir

Package leaflet: Information for the user. Ezetimibe STADA 10 mg, tabletten. Ezetimibe

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan

PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets. Alfuzosin hydrochloride

Package leaflet: Information for the user. Clopidogrel 75 mg film-coated tablets clopidogrel

Package Leaflet: Information for the User. BENETOR 10 mg, 20 mg, 40 mg Film-Coated Tablets olmesartan medoxomil

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

Package leaflet: Information for the patient

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

Package Leaflet: Information for the User. Glucosamine sulfate 750 mg Film-Coated Tablets

Package leaflet: Information for the user. Ezetimibe 10 mg Tablets. Ezetimibe

Package leaflet: Information for the patient

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets

Transcription:

Package leaflet: information for the user Tevanate Once Weekly 70 mg Tablets Alendronic acid Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Tevanate Once Weekly 70 mg Tablets is and what it is used for 2. What you need to know before you take Tevanate Once Weekly 70 mg Tablets 3. How to take Tevanate Once Weekly 70 mg Tablets 4. Possible side effects 5. How to store Tevanate Once Weekly 70 mg Tablets 6. Contents of the pack and other information 1. What Tevanate Once Weekly 70 mg Tablets is and what it is used for Tevanate Once Weekly 70 mg Tablets belongs to a group of drugs called bisphosphonates, which prevent bone loss from the body. Your medicine is used to treat osteoporosis (thinning of the bones) in post-menopausal women. It will reduce your risk of back and hip fractures. 2. What you need to know before you take Tevanate Once Weekly 70 mg Tablets Do not take Tevanate Once Weekly 70 mg Tablets If you are allergic to alendronic acid or any of the other ingredients of this medicine (listed in section 6) If you suffer from certain disorders of the oesophagus (also called the gullet, the tube that connects your mouth with your stomach) If you are unable to stand or sit upright for at least 30 minutes If you have been told by your doctor that you have low blood calcium levels. Warnings and precautions Talk to your doctor or pharmacist before taking Tevanate Once Weekly 70 mg Tablets: If you have difficulty swallowing If your doctor has told you that you have Barrett s oesophagus (a condition associated with changes in the cells that line the lower oesophagus) If you have inflammation of the stomach lining or the duodenum (first section of the small intestine) If you have had surgery on your stomach or gullet (not including pyloroplasty where the outlet from the stomach is widened) in the last year If you have a stomach ulcer or other digestive problems If you have kidney problems. 1

It is important to tell your doctor before you take Tevanate Once Weekly 70 mg Tablets If you have cancer If you are undergoing chemotherapy or radiotherapy If you are taking steroids If you are not receiving routine dental care If you have gum disease If you smoke Appropriate preventive dental care, as recommended by the dentist, should be followed during treatment. Other medicines and Tevanate Once Weekly 70 mg Tablets Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. Talk to your doctor before you take non-steroidal anti-inflammatory drugs (NSAID s) while taking Alendronic Acid. Do not take any other oral medication at the same time as taking this medicine. If you are taking any other oral medication you should leave at least 30 minutes between your dose of this medicine and your other medication. Tevanate Once Weekly 70 mg Tablets with food and drink These tablets should be taken on an empty stomach as food and drink can greatly reduce the effectiveness of the medicine. Take the tablets at least 30 minutes before your first meal of the day. Children and Adolescents: Tevanate Once Weekly 70 mg Tablets should not be given to children and adolescents. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Driving and using machines In some cases this medicine may cause adverse reactions that may affect your ability to drive or operate machinery (like problems with sight). Do not drive or operate machinery if you are affected. 3. How to take Tevanate Once Weekly 70 mg Tablets Once Weekly Always take this medicine as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Your doctor has decided the dose which is suited to you. The following instructions are particularly important to ensure your medicine is effective and to reduce the potential for the medicine to irritate your oesophagus (the tube that connects your mouth with your stomach): Choose the day of the week when you will take your tablet that best fits your schedule. Every week, take one Tevanate Once Weekly 70 mg Tablet on your chosen day Your medicine should be taken on an empty stomach immediately on rising in the morning. It should be taken with a full glass of plain water (not tea, coffee, mineral water or juice) half an hour before any food, drink or other medication 2

The tablets should be swallowed whole, not chewed or sucked Do not lie down after taking your tablet. You must stay upright (sitting, standing or walking) until you have taken your first meal of the day which must be at least half an hour after your dose of Tevanate Once Weekly 70 mg Tablets Do not take your tablets at bedtime or before getting out of bed If you develop pain or difficulty on swallowing, chest pain or new or worsening heartburn, stop taking this medicine and contact your doctor. The usual dosage instructions are given below: Adults (including the elderly): One 70 mg tablet once a week. Children and adolescents: Alendronate should not be given to children and adolescents. If you take more Tevanate Once Weekly 70 mg Tablets than you should If you (or someone else) swallow a lot of the tablets altogether, or if you think a child has swallowed any of the tablets, contact your nearest hospital casualty department or your doctor immediately. Drink a full glass of milk and do not lie down. Overdose can cause painful muscle spasms, tiredness, weakness, exhaustion and fits. It can also cause an upset stomach, indigestion and painful inflammation of the upper digestive system. If you forget to take Tevanate Once Weekly 70 mg Tablets If you forget to take a tablet, take one on rising the next morning. Never take two doses together or on the same day. Return to taking one tablet once a week as originally scheduled on your chosen day. Do not take a double dose to make up for a forgotten tablet. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, this medicine can have side effects, although not everybody gets them. Serious side effects As can happen with any medicine, a few people may develop an allergic reaction. If you experience the following, tell your doctor immediately or go to the casualty department at your nearest hospital: Uncommon: may affect up to 1 in 100 people Eye inflammation (usually painful) Rare: may affect up to 1 in 1,000 people Allergic reaction, including hives and rapid swelling of the skin and mucous membranes (urticaria and angioedema), difficulty breathing, swelling of the lips, face and neck A severe skin reaction with extensive blistering and peeling, which leaves the skin looking scalded (toxic epidermal necrolysis) A severe reaction with small blisters on reddish or purplish, flat, thickened patches of skin, including around or in the mouth and/or eyes and/or genital area (Stevens-Johnson syndrome) Rash on exposure to sunlight Jaw problems (generally following tooth extraction and/or local infection) Unusual fracture of the thigh bone 3

Very rare: may affect up to 1 in 10,000 people Talk to your doctor if you have ear pain, discharge from the ear, and/or an ear infection. These could be signs of bone damage in the ear. If you develop difficulty or pain when swallowing, pain behind the breastbone (centre of the chest), or new or worsening heartburn, stop taking your tablets and contact your doctor. Other side effects The following side effects have been reported at the approximate frequencies shown: Very common: may affect more than 1 in 10 people Pain in the bones, muscles or joints, sometimes severe Common: may affect up to 1 in 10 people Abdominal pain, indigestion or heartburn, constipation, diarrhoea, wind Ulcer of the oesophagus (gullet), difficulty swallowing, full or bloated feeling in the stomach, regurgitation of acid from the stomach Headache, dizziness Joint swelling, swelling in the hands or legs (oedema) Itching, hair loss Tiredness. Uncommon: may affect up to 1 in 100 people Rashes and reddening of the skin Nausea (feeling sick), vomiting (being sick), inflammation of the gullet or stomach, damage to the surface of the gullet which may cause pain and difficulty swallowing, black tarry stools Changes in the sense of taste Transient symptoms (pain in the muscles, malaise and rarely fever) at the initiation of the treatment. Rare: may affect up to 1 in 1,000 people Low blood calcium levels Narrowing of the gullet, mouth, stomach and other peptic ulcers Blood calcium and phosphate levels may be affected by Tevanate Once Weekly 70 mg Tablets, but you may not experience symptoms. Unusual fracture of the thigh bone particularly in patients on long-term treatment for osteoporosis may occur rarely. Contact your doctor if you experience pain, weakness or discomfort in your thigh, hip or groin as this may be an early indication of a possible fracture of the thigh bone. Osteonecrosis (arthritis) of the jaw (jaw problems, generally following tooth extraction and/or local infection) has been reported in patients treated with bisphosphonates including alendronic acid. Osteonecrosis of the jaw has mainly been reported in patients treated for cancer, but some cases have also been reported in patients treated for osteoporosis. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. 4

5. How to store Tevanate Once Weekly 70 mg Tablets Keep this medicine out of the sight and reach of children. This medicinal product does not require any special storage conditions. Do not use this medicine after the expiry date which is stated on the outer packaging. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6. Contents of the pack and other information What Tevanate Once Weekly 70 mg Tablets contains The active ingredient is alendronic acid. Each tablet contains 70 mg alendronic acid (as sodium monohydrate). The other ingredients are microcrystalline cellulose, croscarmellose sodium and magnesium stearate. What Tevanate Once Weekly 70 mg Tablets looks like and contents of the pack The name of your medicine is Tevanate Once Weekly 70 mg Tablets. The product is available in pack sizes of 2, 4, 8, 12, 40 and 50 tablets. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder Teva Pharma B.V. Swensweg 5 2031GA Haarlem The Netherlands Manufacturer Teva Pharmaceutical Works Private Limited Company, Pallagi út 13, 4042 Debrecen, Hungary. Teva UK Ltd., Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG, UK. Pharmachemie B.V., Swensweg 5, Postbus 552, 2003 RN Haarlem, The Netherlands. This medicinal product is authorised in the Member States of the EEA under the following names: Belgium Czech Republic Denmark Germany Greece Hungary Ireland Italy Lithuania Netherlands Norway Portugal Alendronate TEVA 70 mg tabletten Alendronate Teva 70 mg Alendronat TEVA Tevanate 70 mg Tabletten TEVANATE Δισκία 70 mg Trabecan-Teva 70 mg Tabletta Tevanate Once Weekly 70 mg Tablets Alendronato Teva TEVANATE 70 mg tablets Alendroninezuur 70 PCH, tabletten 70 mg Alendronat TEVA 70 mg tablett Acido Alendronico Teva 70 mg comprimidos 5

Spain Sweden United Kingdom Acido Alendronico Teva 70 mg comprimidos EFG Alendronat Teva Veckotablett 70 mg tabletter Alendronic acid 70 mg Tablets This leaflet was last revised in: June 2016 6